1 Bi, Q. et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis, 30287-30285 (2020).
2 Hou, Y. J., Okuda, K., Edwards, C. & al, e. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract. Cell, 10.1016/j.cell.2020.1005.1042 (2020).
3 World Heatlh Organization. Coronavirus disease (COVID-2019) situation reports 153. (2020).
4 Jose, R. & Manuel, A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med, 30216-30212 (2020).
5 Wang, F. et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J Infect Dis, 10.1093/infdis/jiaa1150 (2020).
6 Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 507-513 (2020).
7 Guo, C., Li, B., Ma, H. & al, e. Tocilizumab treatment in severe COVID-19 patients attenuates the inflammatory storm incited by monocyte centric immune interactions revealed by single-cell analysis. Preprinted in bioRxiv, 10.1101/2020.1104.1108.029769 (2020).
8 Wen, W. et al. Immune Cell Profiling of COVID-19 Patients in the Recovery Stage by Single-Cell Sequencing. Cell Discov, 10.1038/s41421-41020-40168-41429 (2020).
9 Zini, G., Bellesi, S., Ramundo, F. & d'Onofrio, G. Morphological anomalies of circulating blood cells in COVID-19. Am J Hematol, 10.1002/ajh.25824 (2020).
10 de Laval, B. et al. C/EBPbeta-Dependent Epigenetic Memory Induces Trained Immunity in Hematopoietic Stem Cells. Cell Stem Cell 26, 793, doi:10.1016/j.stem.2020.03.014 (2020).
11 Hadjadj, J., Yatim, N., Barnabei, L. & al, e. Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients. Preprinted in medRxiv, 10.1101/2020.1104.1119.20068015 (2020).
12 Sallard, E., Lescure, F., Yazdanpanah, Y., Mentre, F. & Peiffer-Smadja, N. Type 1 interferons as a potential treatment against COVID-19. Antiviral Res, 10.1016/j.antiviral.2020.104791 (2020).
13 Zheng, G., Terry, J., Belgrader, P. & al, e. Massively parallel digital transcriptional profiling of single cells. Nat Commun, 14049-14061 (2017).
14 Kindler, E., Thiel, V. & Weber, F. Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response. Adv Virus Res 96, 219-243, doi:10.1016/bs.aivir.2016.08.006 (2016).
15 Dosch, S. F., Mahajan, S. D. & Collins, A. R. SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kappaB pathway in human monocyte macrophages in vitro. Virus Res 142, 19-27, doi:10.1016/j.virusres.2009.01.005 (2009).
16 Choudhury, A. & Mukherjee, S. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. J Med Virol, doi:10.1002/jmv.25987 (2020).
17 Takizawa, H., Boettcher, S. & Manz, M. G. Demand-adapted regulation of early hematopoiesis in infection and inflammation. Blood 119, 2991-3002, doi:10.1182/blood-2011-12-380113 (2012).
18 Vadillo, E. & Pelayo, R. [Toll-like receptors in development and function of the hematopoietic system]. Rev Invest Clin 64, 461-476 (2012).
19 Sioud, M. & Floisand, Y. TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response. Eur J Immunol 37, 2834-2846, doi:10.1002/eji.200737112 (2007).
20 Sioud, M., Floisand, Y., Forfang, L. & Lund-Johansen, F. Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage. J Mol Biol 364, 945-954, doi:10.1016/j.jmb.2006.09.054 (2006).
21 De Luca, K. et al. The TLR1/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate. Leukemia 23, 2063-2074, doi:10.1038/leu.2009.155 (2009).
22 Zhang, D. et al. COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome. Preprinted in medRxiv, 10.1101/2020.1103.1124.20042655 (2020).
23 Kirby, M., Weitzman, S. & Freedman, M. Juvenile chronic myelogenous leukemia: differentiation from infantile cytomegalovirus infection. Am J Pediatr Hematol Oncol, 292-296 (1990).
24 Herrod, H., Dow, L. & Sullivan, J. Persistent Epstein-Barr virus infection mimicking juvenile myelogenous leukemia: immunologic and hematologic studies. Blood, 1098-1104 (1983).
25 Yetgin, S., Cetin, M., Yenicesu, I., Ozaltin, F. & Uckan, D. acute parvovirus B19 infection mimicking juvenile myelomonocytic leukemia. Eur J Haematol, 276-278 (2000).
26 Novershtern, N. et al. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell 144, 296-309, doi:10.1016/j.cell.2011.01.004 (2011).
27 Tang-Huau, T. L. et al. Human in vivo-generated monocyte-derived dendritic cells and macrophages cross-present antigens through a vacuolar pathway. Nat Commun 9, 2570, doi:10.1038/s41467-018-04985-0 (2018).
28 Lambert, C., Preijers, F., Yanikkaya Demirel, G. & Sack, U. Monocytes and macrophages in flow: an ESCCA initiative on advanced analyses of monocyte lineage using flow cytometry. Cytometry B Clin Cytom 92, 180-188, doi:10.1002/cyto.b.21280 (2017).
29 Grassi, L. et al. Dynamics of Transcription Regulation in Human Bone Marrow Myeloid Differentiation to Mature Blood Neutrophils. Cell Rep 24, 2784-2794, doi:10.1016/j.celrep.2018.08.018 (2018).
30 Mitra, A. et al. Leukoerythroblastic reaction in a patient with COVID-19 infection. Am J Hematol, 10.1002.25793 (2020).
31 Hamers, A. A. J. et al. Human Monocyte Heterogeneity as Revealed by High-Dimensional Mass Cytometry. Arterioscler Thromb Vasc Biol 39, 25-36, doi:10.1161/ATVBAHA.118.311022 (2019).
32 Pruenster, M. et al. Extracellular MRP8/14 is a regulator of beta2 integrin-dependent neutrophil slow rolling and adhesion. Nat Commun 6, 6915, doi:10.1038/ncomms7915 (2015).
33 Schnoor, M., Alcaide, P., Voisin, M. B. & van Buul, J. D. Crossing the Vascular Wall: Common and Unique Mechanisms Exploited by Different Leukocyte Subsets during Extravasation. Mediators Inflamm 2015, 946509, doi:10.1155/2015/946509 (2015).
34 Chen, G. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130, 2620-2629, doi:10.1172/JCI137244 (2020).
35 Vadillo, E. et al. Adult, but not neonatal, human lymphoid progenitors respond to TLR9 ligation by producing functional NK-like cells. Exp Hematol 42, 562-573 e563, doi:10.1016/j.exphem.2014.03.008 (2014).
36 Welner, R. S. et al. Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection. Blood 112, 3753-3761, doi:10.1182/blood-2008-04-151506 (2008).
37 Nagai, Y. et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 24, 801-812, doi:10.1016/j.immuni.2006.04.008 (2006).
38 Hoogendijk, A. J. et al. Dynamic Transcriptome-Proteome Correlation Networks Reveal Human Myeloid Differentiation and Neutrophil-Specific Programming. Cell Rep 29, 2505-2519 e2504, doi:10.1016/j.celrep.2019.10.082 (2019).
39 Itelman, E. et al. Clinical Characterization of 162 COVID-19 patients in Israel: Preliminary Report from a Large Tertiary Center. Isr Med Assoc J 22, 271-274 (2020).